CymaBay Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
CymaBay Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q4 2023.
  • CymaBay Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending December 31, 2023 was 114M shares, a 34.5% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 114M +29.2M +34.5% Dec 31, 2023 10-K 2024-02-28
Q3 2023 113M +28.6M +33.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 97.8M +13.1M +15.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 97.3M +12.7M +14.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 84.7M +3.12K +0% Dec 31, 2022 10-K 2024-02-28
Q3 2022 84.7M +15.6M +22.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 84.7M +15.7M +22.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 84.7M +15.7M +22.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 84.7M +15.7M +22.8% Dec 31, 2021 10-K 2023-03-23
Q3 2021 69M +157K +0.23% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 69M +111K +0.16% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 68.9M +63.6K +0.09% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 68.9M +63.6K +0.09% Dec 31, 2020 10-K 2022-03-17
Q3 2020 68.9M +186K +0.27% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 68.9M +186K +0.27% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 68.9M +188K +0.27% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 68.9M +9.43M +15.9% Dec 31, 2019 10-K 2021-03-25
Q3 2019 68.7M +9.26M +15.6% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 68.7M +9.74M +16.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 68.7M +9.98M +17% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 59.5M +15M +33.9% Dec 31, 2018 10-K 2020-03-16
Q3 2018 59.4M +15.6M +35.6% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 59M +30.2M +105% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 58.7M +30M +104% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 44.4M +21M +89.4% Dec 31, 2017 10-K 2019-02-28
Q3 2017 43.8M +20.4M +87% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 28.8M +5.31M +22.6% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 28.8M +5.31M +22.6% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 23.4M 0 0% Dec 31, 2016 10-K 2018-03-15
Q3 2016 23.4M 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 23.4M +8.19M +53.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 23.4M +8.2M +53.8% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 23.4M +8.75M +59.5% Dec 31, 2015 10-K 2017-03-23
Q3 2015 23.4M +8.76M +59.7% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 15.3M +5.19M +51.6% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 15.2M +5.18M +51.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 14.7M +5.24M +55.4% Dec 31, 2014 10-K 2016-03-29
Q3 2014 14.7M +9.32M +174% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 10.1M Jun 30, 2014 10-Q 2014-08-14
Q1 2014 10.1M Mar 31, 2014 10-Q 2014-05-15
Q4 2013 9.46M +9.45M +163144% Dec 31, 2013 10-K 2015-03-23
Q3 2013 5.37M Sep 30, 2013 10-K 2015-03-23
Q4 2012 5.79K* Dec 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.